Skip to Content

New Drug Approvals Archive - January 2014

January 2014

Farxiga (dapagliflozin) Tablets

Date of Approval: January 8, 2014
Company: Bristol-Myers Squibb Company and AstraZeneca
Treatment for: Diabetes Type 2

Farxiga (dapagliflozin) is a selective sodium-glucose cotransporter-2 inhibitor for the treatment of adults with type 2 diabetes mellitus.

Aleve PM (diphenhydramine hydrochloride and naproxen sodium) Caplets

Date of Approval: January 16, 2014
Company: Bayer HealthCare LLC, Consumer Care
Treatment for: Pain, Insomnia

Aleve PM (diphenhydramine hydrochloride and naproxen sodium) is an over-the-counter antihistamine and nonsteroidal anti-inflammatory drug (NSAID) combination for the relief of occasional sleeplessness associated with minor aches and pains.

Hetlioz (tasimelteon) Capsules

Date of Approval: January 31, 2014
Company: Vanda Pharmaceuticals Inc.
Treatment for: Non-24-Hour Disorder

Hetlioz (tasimelteon) is a melatonin receptor agonist for the treatment of Non-24-Hour Disorder in the totally blind.

Retin-A Micro (tretinoin)

New Dosage Form Approved:

New Drug Approvals Archive

More News Resources

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.